Author

Ioannis Kourtzelis

University of YorkPrimary ORCID profile (0000-0003-3006-8885 · 2 papers)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Ioannis KourtzelisiD2 papers · University of York

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

Alina L. Capatina· 1 shared Benjamin R. LichmaniD· 1 shared Charlotte Plunkett-Jones· 1 shared Dimitris LagosiD· 1 shared Ian A. GrahamiD· 1 shared Thierry TononiD· 1 shared Tomasz CzechowskiiD· 1 shared William J. BrackenburyiD· 1 shared

Activity by Year

2026-2026 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 28 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alina L. Capatina

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Artemether and Euphorbia Factor L9 suppress kynurenine production through distinct effects on Tryptophan metabolism.

Alina L. Capatina, Tomasz Czechowski, Charlotte Plunkett-Jones, Thierry Tonon, Ioannis Kourtzelis, Benjamin R. Lichman, William J. Brackenbury, Ian A. Graham, Dimitris Lagos

This study identifies artemether and EFL9 as inhibitors of kynurenine production through distinct mechanisms, offering potential new therapeutic approaches for targeting tryptophan metabolism.

Biochemical Journal · Mar 13, 2026Peer-reviewedCancer Biology